Shareholder Class Action | Courthouse News Service
Sunday, December 3, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

WILMINGTON, Del. - MAP Pharmaceuticals is selling itself too cheaply to Allergan, for $25 a share or $958 million, shareholders claim in Chancery Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...